Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1095411.RAjb2-dKrEj136GssXuiB5Dhr0VWToMck2DWtdvpjBa7Q130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1095411.RAjb2-dKrEj136GssXuiB5Dhr0VWToMck2DWtdvpjBa7Q130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1095411.RAjb2-dKrEj136GssXuiB5Dhr0VWToMck2DWtdvpjBa7Q130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1095411.RAjb2-dKrEj136GssXuiB5Dhr0VWToMck2DWtdvpjBa7Q130_provenance.
- NP1095411.RAjb2-dKrEj136GssXuiB5Dhr0VWToMck2DWtdvpjBa7Q130_assertion description "[EGF receptor (EGFR) kinase inhibitors, including gefitinib and erlotinib, exert potent therapeutic efficacy in non-small cell lung cancers harboring EGFR-activating mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1095411.RAjb2-dKrEj136GssXuiB5Dhr0VWToMck2DWtdvpjBa7Q130_provenance.
- NP1095411.RAjb2-dKrEj136GssXuiB5Dhr0VWToMck2DWtdvpjBa7Q130_assertion evidence source_evidence_literature NP1095411.RAjb2-dKrEj136GssXuiB5Dhr0VWToMck2DWtdvpjBa7Q130_provenance.
- NP1095411.RAjb2-dKrEj136GssXuiB5Dhr0VWToMck2DWtdvpjBa7Q130_assertion SIO_000772 23872583 NP1095411.RAjb2-dKrEj136GssXuiB5Dhr0VWToMck2DWtdvpjBa7Q130_provenance.
- NP1095411.RAjb2-dKrEj136GssXuiB5Dhr0VWToMck2DWtdvpjBa7Q130_assertion wasDerivedFrom befree-2016 NP1095411.RAjb2-dKrEj136GssXuiB5Dhr0VWToMck2DWtdvpjBa7Q130_provenance.
- NP1095411.RAjb2-dKrEj136GssXuiB5Dhr0VWToMck2DWtdvpjBa7Q130_assertion wasGeneratedBy ECO_0000203 NP1095411.RAjb2-dKrEj136GssXuiB5Dhr0VWToMck2DWtdvpjBa7Q130_provenance.
- befree-2016 importedOn "2016-02-19" NP1095411.RAjb2-dKrEj136GssXuiB5Dhr0VWToMck2DWtdvpjBa7Q130_provenance.